|
The quest for a good death
November 9, 2023
-
Dr. Colleen Webber is receiving the Clinical and Applied Health Researcher in Training Award from The Ottawa Hospital for her rigorous and empathetic palliative care research
|
|
Emergency department visits for substance use linked to higher risk of developing schizophrenia
September 27, 2023
-
People visiting the emergency department (ED) for substance use—particularly cannabis—are at high risk of developing schizophrenia, according to new research.
|
|
Could a drug that controls appetite also treat schizophrenia and Alzheimer’s? Mouse studies show promise.
September 8, 2021
-
Two recent studies suggest that the drug trodusquemine has the potential to treat symptoms of both schizophrenia and Alzheimer’s disease. This is because the drug targets an enzyme called PTP1B, which plays a role in both diseases
|
|
A conversation with Dr. Jess Fiedorowicz
August 18, 2021
-
Dr. Jess Fiedorowicz is shining a light on mental health through his work and research at The Ottawa Hospital. Originally from the U.S., Dr. Fiedorowicz has been at our hospital since 2020 as the Head and Chief of the Department of Mental Health.
|
|
Study in mice reveals possible new target to treat schizophrenia
March 10, 2021
-
The enzyme PTP1B may be a new target for treating schizophrenia, according to a study published in Neuropsychopharmacology.
|
|
The Ottawa Hospital awarded 18 research grants from the Canadian Institutes of Health Research, worth $10.7 million
May 19, 2017
-
Eighteen research groups at The Ottawa Hospital, affiliated with the University of Ottawa, have been awarded nearly $11 million in the most recent project grant competition from the Canadian Institutes of Health Research (CIHR). This represents a suc
|